tetano
Editor, Senior Moderator
Emerg Med Pract. 2020 Feb 27;22(2 Suppl 2):1-21. [h=1]Novel coronavirus COVID-19: an overview for emergency clinicians[/h]
Giwa A[SUP]1[/SUP], Desai A[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Prior to the global outbreak of SARS-CoV in 2003, HCoV-229E and HCoV-OC43 were the only coronaviruses known to infect humans. Following the SARS outbreak, 5 additional coronaviruses have been discovered in humans, most recently the novel coronavirus COVID-19, believed to have originated in Wuhan, Hubei Province, China. SARS-CoV and MERSCoV are particularly pathogenic in humans and are associated with high mortality. In this review, the epidemiology, pathophysiology, and management of the recently discovered COVID-19 are reviewed, with a focus on best practices and the public health implications.
PMID: 32105049
Giwa A[SUP]1[/SUP], Desai A[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Prior to the global outbreak of SARS-CoV in 2003, HCoV-229E and HCoV-OC43 were the only coronaviruses known to infect humans. Following the SARS outbreak, 5 additional coronaviruses have been discovered in humans, most recently the novel coronavirus COVID-19, believed to have originated in Wuhan, Hubei Province, China. SARS-CoV and MERSCoV are particularly pathogenic in humans and are associated with high mortality. In this review, the epidemiology, pathophysiology, and management of the recently discovered COVID-19 are reviewed, with a focus on best practices and the public health implications.
PMID: 32105049